Skip to content
Sunday, September 27, 2026 · Riyadh
العربيةNewsletterContact
Saudi Arabia

Jazan Specialist Hospital performs advanced surgery for ovarian cancer patient

A surgical team at Jazan Specialist Hospital has successfully performed an advanced procedure for a patient with advanced ovarian cancer using CRS + HIPEC.

Ajel News43 min ago · 1 min read
Jazan hospital surgical team during ovarian cancer operation

Key Takeaways

AI

A surgical oncology team at Jazan Specialist Hospital has successfully performed an advanced procedure on a patient with widespread ovarian cancer in the abdominal cavity, utilizing cytoreductive surgery combined with heated intraperitoneal chemotherapy (CRS + HIPEC). This intervention is reserved for select cases based on strict medical criteria.

The technique involves removing as much visible tumor as possible from the abdomen, followed by circulating a heated chemotherapy solution within the abdominal cavity for a set period. This targets any microscopic cancer cells that may remain after surgery. The decision to use CRS + HIPEC is made after a thorough medical assessment, considering the extent of disease, the feasibility of tumor removal, and the patient's overall health.

A multidisciplinary medical team, including surgical oncologists, anesthesiologists, intensive care specialists, as well as nursing and support staff, participated in the operation. The complex procedure lasted several hours due to its intricate nature and medical requirements.

CRS + HIPEC is used for selected cases of cancers that have spread within the abdominal cavity and is not suitable for all patients. The decision depends on the type and extent of the tumor, the possibility of removing visible tumors, and the patient's general health condition.

This operation is part of ongoing efforts by Jazan Specialist Hospital and the Jazan Health Cluster to advance oncology surgical services and provide specialized treatments for patients in the region, based on careful medical evaluation tailored to each case.

Comments (0)